http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Yuping Ran (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
Invasive Fungal Infections: Diagnosis and Treatments in China
Yuping Ran 대한의진균학회 2008 대한의진균학회지 Vol.13 No.3
The body location and clinical appearance of fungal infections depends on the fungal virulence, infectious route and host immunological state. The result being that patients with mycoses consult with different clinical departments. The diagnosis of mycoses is based on the detection of fungal elements such as hyphae and/or yeast cells from the involved tissues. Isolation of the fungus is the precondition for species identification and antifungal treatment. To think clinically and to emphasize the mycology is the basic consideration of medical mycology research. Mycologists play a key role in the collaboration between the clinical and laboratory aspects. The clinician always wants to know what the fungus is and how to treatment the mycosis. Fungal pathogens are often stealthy and difficult to detect in infected patients during the early stages of the diseases and this is when therapies would be the most effective. Routine techniques commonly employed in the detection of fungal diseases including microscopic examination, culturing and serology are seriously hampered by lengthy waits of times for results and low accuracy. The clinician may want prophylaxis or to use empirical antifungal treatment to see if it does/does not work. The problem is that some of the patients do not respond to the antifungal treatment, because the doctor lacked sufficient evidence of fungus infection to give the doctor confidence to continue treatment. Accurate and early diagnosis of fungal diseases is critical for managing mycotic diseases. This is usually done by direct microscopic examination (DME) of KOH preparations. Good specimens are the key point that directly affects the quality of microscopic evidence and culture. The most important aspect is culturing samples on different media with or without chloramphenicol and cycloheximide and incubated at room temperature and 37℃. Early treatment could save a patient's life. We start treatment at the time we have the proof of fungal infection, i.e., KOH positive. Itraconazole, fluconazole, terbinafine, amphotericin B or its liposome form, can be used alone or in combination based on the fungal species involved and the site of infection. The body location and clinical appearance of fungal infections depends on the fungal virulence, infectious route and host immunological state. The result being that patients with mycoses consult with different clinical departments. The diagnosis of mycoses is based on the detection of fungal elements such as hyphae and/or yeast cells from the involved tissues. Isolation of the fungus is the precondition for species identification and antifungal treatment. To think clinically and to emphasize the mycology is the basic consideration of medical mycology research. Mycologists play a key role in the collaboration between the clinical and laboratory aspects. The clinician always wants to know what the fungus is and how to treatment the mycosis. Fungal pathogens are often stealthy and difficult to detect in infected patients during the early stages of the diseases and this is when therapies would be the most effective. Routine techniques commonly employed in the detection of fungal diseases including microscopic examination, culturing and serology are seriously hampered by lengthy waits of times for results and low accuracy. The clinician may want prophylaxis or to use empirical antifungal treatment to see if it does/does not work. The problem is that some of the patients do not respond to the antifungal treatment, because the doctor lacked sufficient evidence of fungus infection to give the doctor confidence to continue treatment. Accurate and early diagnosis of fungal diseases is critical for managing mycotic diseases. This is usually done by direct microscopic examination (DME) of KOH preparations. Good specimens are the key point that directly affects the quality of microscopic evidence and culture. The most important aspect is culturing samples on different media with or without chloramphenicol and cycloheximide and incubated at room temperature and 37℃. Early treatment could save a patient's life. We start treatment at the time we have the proof of fungal infection, i.e., KOH positive. Itraconazole, fluconazole, terbinafine, amphotericin B or its liposome form, can be used alone or in combination based on the fungal species involved and the site of infection.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
